Achema middle east

Industry Reports

Ardena acquires ChemConnection adding API expertise

Contract development and manufacturing organisation (CDMO) Ardena has acquired ChemConnection, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines. Originating from Organon and Merck Sharp & Dohme (MSD) in 2012, Netherlands-based ChemConnection has rapidly evolved to become...

Sessa Capital Im LP decline Its Bristol Myers Squibb Co (BMY) Position by $272.76 Million

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It is positive, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares...

The Flatiron Health Acquisitio could make things better For Roche’s Oncology Real-World Evidence Needs

Why Roche paid $1.9 billion for a 5-year-old companyEarlier this month, Roche, a global pharmaceutical giant, acquired Flatiron Health, an oncology-focused electronic health records (EHR) company, for $1.9 billion. Prior to this, Roche had a 12.6% stake in the...

InDex Pharmaceuticals Holding AB (publ) Year end Report 2017

Period October – December 2017 Revenues amounted to SEK 0.0 (0.3) million Operating result amounted to SEK –22.6 (–16.4) million Result after tax amounted to SEK –22.4 (–16.3) million,corresponding to SEK –0.36 per share (–0.27) before and after...

Swedish Primary care group Novakliniken being acquired by Capio

Capio has signed an agreement to acquire 100% of Novakliniken with operations in the southeastern parts of Skåne, Sweden. Novakliniken operates eight primary care centers and two branches, and provides some occupational health and dental services. ...

Reckitt Benckiser’s proposal to buy Pfizer makes sense says JP Morgan

Reckitt Benckiser Group PLC is attempting to buy Pfizer Inc’s consumer healthcare business and analysts at JP Morgan think a potential deal makes sense. “We see a potential acquisition as a strategic step toward building a...

Merck signs its acquisition agreement with Viralytics to Increase its Leading Immuno-Oncolgy Pipeline

Merck , known as MSD outside the USA and Canada, and Viralytics Limited announced that the companies have signed a definitive agreement under which it is proposed that Merck, through a subsidiary, will acquire Viralytics, an Australian publicly traded...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »